Neutrophil Activation Promotes Fibrinogen Oxidation and Thrombus Formation in Behçet Disease

Background— Behçet disease (BD) is a systemic vasculitis with a broad range of organ involvement, characterized by a multisystemic, immune-inflammatory disorder involving vessels of all sizes and often complicated by thrombosis. Systemic redox imbalance and circulating neutrophil hyperactivation have been observed in BD patients and are thought to be responsible for impaired coagulation. We here focused on the pathogenetic mechanisms potentially linking immune cell activation and thrombosis, and specifically examined whether neutrophil activation can affect fibrinogen modifications and consequently elicit thrombosis. Methods and Results— Blood samples were collected from 98 consecutive BD patients attending our dedicated Center and from 70 age- and sex-matched healthy controls; in all patients fibrinogen function and structure, fibrin susceptibility to plasmin-lysis, plasma redox status, leukocyte oxidative stress markers, and possible reactive oxygen species sources were examined. Thrombin-catalyzed fibrin formation and fibrin susceptibility to plasmin-induced lysis were significantly impaired in BD patients (P<0.001). These findings were associated with increased plasma oxidative stress markers (P<0.001) and with a marked carbonylation of fibrinogen (P<0.001), whose secondary structure appeared deeply modified. Neutrophils displayed an enhanced NADPH oxidase activity and increased reactive oxygen species production (P<0.001), which significantly correlated with fibrinogen carbonylation level (r2=0.33, P<0.0001), residual &bgr;-band intensity (r2=0.07, P<0.01), and fibrinogen clotting ability (r2=0.073, P<0.01) Conclusions— In BD patients, altered fibrinogen structure and impaired fibrinogen function are associated with neutrophil activation and enhanced reactive oxygen species production whose primary source is represented by neutrophil NADPH oxidase.

[1]  M. Schirmer,et al.  Major vessel involvement in Behçet's disease: an update , 2011, Current opinion in rheumatology.

[2]  N. Taddei,et al.  Altered redox status in the blood of psoriatic patients: involvement of NADPH oxidase and role of anti-TNF-α therapy , 2013, Redox report : communications in free radical research.

[3]  G. Hart,et al.  In vitro oxidative damage to tissue-type plasminogen activator: a selective modification of the biological functions. , 1995, Cardiovascular research.

[4]  A. Azhar,et al.  Studies on fibrin network structure in human plasma. Part II--Clinical application: diabetes and antidiabetic drugs. , 1991, Thrombosis research.

[5]  S. Reddy,et al.  Reactive oxygen species in inflammation and tissue injury. , 2014, Antioxidants & redox signaling.

[6]  M. Bottai,et al.  Fibrin resistance to lysis in patients with pulmonary hypertension other than thromboembolic. , 2010, American journal of respiratory and critical care medicine.

[7]  K. Haskins,et al.  A Citrullinated Fibrinogen-Specific T Cell Line Enhances Autoimmune Arthritis in a Mouse Model of Rheumatoid Arthritis , 2013, The Journal of Immunology.

[8]  Owen J T McCarty,et al.  Quantification of volume, mass, and density of thrombus formation using brightfield and differential interference contrast microscopy , 2013, Journal of biomedical optics.

[9]  Mehran Ghasemzadeh,et al.  Platelet-leukocyte crosstalk: Linking proinflammatory responses to procoagulant state. , 2013, Thrombosis research.

[10]  J. Weisel,et al.  Deglycosylation of fibrinogen accelerates polymerization and increases lateral aggregation of fibrin fibers. , 1988, The Journal of biological chemistry.

[11]  K. Krause,et al.  The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. , 2007, Physiological reviews.

[12]  W. Robinson,et al.  Autoimmunity against Fibrinogen Mediates Inflammatory Arthritis in Mice , 2009, The Journal of Immunology.

[13]  K. Aksu,et al.  Inflammation-induced thrombosis: mechanisms, disease associations and management. , 2012, Current pharmaceutical design.

[14]  G. Fernández,et al.  Soluble Fibrinogen Modulates Neutrophil Functionality Through the Activation of an Extracellular Signal-Regulated Kinase-Dependent Pathway1 , 2002, The Journal of Immunology.

[15]  H. Nakauchi,et al.  In vivo imaging visualizes discoid platelet aggregations without endothelium disruption and implicates contribution of inflammatory cytokine and integrin signaling. , 2012, Blood.

[16]  J. Weisel,et al.  Computer modeling of fibrin polymerization kinetics correlated with electron microscope and turbidity observations: clot structure and assembly are kinetically controlled. , 1992, Biophysical journal.

[17]  T. Ugarova,et al.  Integrin αMβ2-Mediated Cell Migration to Fibrinogen and Its Recognition Peptides , 2001, The Journal of experimental medicine.

[18]  P. Ridker.  Moving Beyond JUPITER: Will Inhibiting Inflammation Reduce Vascular Event Rates? , 2012, Current Atherosclerosis Reports.

[19]  A. Silman,et al.  EULAR recommendations for the management of Behçet disease , 2008, Annals of the rheumatic diseases.

[20]  Matteo Becatti,et al.  Thrombosis in vasculitis: from pathogenesis to treatment , 2015, Thrombosis Journal.

[21]  T. Ergun,et al.  Neutrophil activation in Behçet's disease. , 2001, Clinical and experimental rheumatology.

[22]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[23]  O. Ozcebe,et al.  Behçet's disease. , 2019, The New England journal of medicine.

[24]  Y. Ozyazgan,et al.  Relation of protein oxidation parameters and disease activity in patients with Behçet's disease. , 2013, Clinical laboratory.

[25]  M. Verhaar,et al.  Endothelial progenitor cell dysfunction in rheumatic disease , 2009, Nature Reviews Rheumatology.

[26]  B. Engelmann,et al.  Thrombosis as an intravascular effector of innate immunity , 2012, Nature Reviews Immunology.

[27]  J. Williams,et al.  Oxidative modification of fibrinogen inhibits thrombin-catalyzed clot formation. , 1995, Free radical biology & medicine.

[28]  T. Ugarova,et al.  Recognition of Fibrinogen by Leukocyte Integrins , 2001, Annals of the New York Academy of Sciences.

[29]  M. Blombäck,et al.  Proneness to Formation of Tight and Rigid Fibrin Gel Structures in Men with Myocardial Infarction at a Young Age , 1996, Thrombosis and Haemostasis.

[30]  M. Blombäck,et al.  Fibrin Gel Network Characteristics and Coronary Heart Disease: Relations to Plasma Fibrinogen Concentration, Acute Phase Protein, Serum Lipoproteins and Coronary Atherosclerosis , 1992, Thrombosis and Haemostasis.

[31]  R. Olinescu,et al.  Fibrinogen is an efficient antioxidant. , 2001, The Journal of nutritional biochemistry.

[32]  P. Merkel,et al.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. , 2013, Arthritis and rheumatism.

[33]  H. Yazıcı,et al.  Fibrinolytic activity and d-dimer levels in Behçet's syndrome. , 2005, Clinical and experimental rheumatology.

[34]  S. Brennan,et al.  Fibrinogen Bβ polymorphisms do not directly contribute to an altered in vitro clot structure in humans , 2003, Thrombosis and Haemostasis.

[35]  R. Abbate,et al.  Evidence for oxidative stress in plasma of patients with Marfan syndrome. , 2010, International journal of cardiology.

[36]  V. Uversky,et al.  Conformational behavior and aggregation of alpha-synuclein in organic solvents: modeling the effects of membranes. , 2003, Biochemistry.

[37]  N. Maugeri,et al.  Translational Mini‐Review Series on Immunology of Vascular Disease: Mechanisms of vascular inflammation and remodelling in systemic vasculitis , 2009, Clinical and experimental immunology.

[38]  Betti Giusti,et al.  Oxidative Modification of Fibrinogen Is Associated With Altered Function and Structure in the Subacute Phase of Myocardial Infarction , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[39]  A. Akar,et al.  Correlation between erythrocyte antioxidant activity, lipid peroxidation, and disease activity in patients with Behçet's disease , 2003, Journal of the European Academy of Dermatology and Venereology : JEADV.

[40]  D. Wagner,et al.  Thrombosis: tangled up in NETs. , 2014, Blood.

[41]  M. Aslan,et al.  Oxidases and oxygenases in regulation of neutrophil redox pathways in Behçet’s disease patients , 2012, Journal of enzyme inhibition and medicinal chemistry.

[42]  A. Silman,et al.  [Criteria of diagnosis of Behcet's disease]. , 1975, La Tunisie medicale.

[43]  A. Azhar,et al.  Studies on fibrin network structure in human plasma. Part One: Methods for clinical application. , 1991, Thrombosis research.

[44]  K. Preissner,et al.  Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases , 2010, Nature Medicine.

[45]  J. Freyssinet,et al.  Microparticles: a critical component in the nexus between inflammation, immunity, and thrombosis , 2011, Seminars in Immunopathology.

[46]  A. Walch,et al.  Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo , 2012, The Journal of experimental medicine.